(S (NP (NNP Psoas) (NN muscle) (NNS measurements)) (VP (VBP are) (ADVP (RB frequently)) (VP (VBN used) (PP (IN as) (NP (NP (NP (NNS markers)) (PP (IN of) (NP (NNP sarcopenia)))) (CC and) (NP (NP (NNS predictors)) (PP (IN of) (NP (NN health)))))))) (. .))
(S (S (NP (ADJP (RB Manually) (VBN measured)) (JJ cross-sectional) (NNS areas)) (VP (VBP are) (ADVP (RBS most) (RB commonly)) (VP (VBN used)))) (, ,) (CC but) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (NN consistency)) (PP (VBG regarding) (NP (NP (DT the) (NN position)) (PP (IN of) (NP (NP (DT the) (NN measurementand)) (SBAR (S (NP (JJ manual) (NNS annotations)) (VP (VBP are) (RB not) (ADJP (JJ practical) (PP (IN for) (NP (JJ large) (NN population) (NNS studies)))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (S (NP (DT a) (RB fully) (VBN automated) (NN method)) (VP (TO to) (VP (VB measure) (NP (NP (NP (NNS iliopsoas) (NML (NN muscle) (NN volume))) (-LRB- -LRB-) (VP (VBN comprised) (PP (IN of) (NP (NP (DT the) (NNS psoas)) (CC and) (NP (NN iliacus) (NNS muscles))))) (-RRB- -RRB-)) (VP (VBG using) (NP (DT a) (JJ convolutional) (JJ neural) (NN network))))))))) (. .))
(S (NP (JJ Magnetic) (NN resonance) (NNS images)) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (DT the) (NNP UK) (NNP Biobank))) (PP (IN for) (NP (NP (CD 5,000) (ADJP (JJ male) (CC and) (JJ female)) (NNS participants)) (, ,) (VP (VBN balanced) (PP (IN for) (NP (NN age) (, ,) (NN gender) (CC and) (NN BMI)))))))) (. .))
(S (NP (CD Ninety) (JJ manual) (NNS annotations)) (VP (VBD were) (ADJP (JJ available) (PP (IN for) (NP (NN model) (NN training) (CC and) (NN validation))))) (. .))
(S (NP (DT The) (NN model)) (VP (VBD showed) (NP (JJ excellent) (NN performance)) (PP (IN against) (NP (NP (NML (PP (ADVP (IN out)) (HYPH -) (IN of) (HYPH -) (NP (NN sample)))) (NNS data)) (-LRB- -LRB-) (NP (NP (NNS dice)) (NP (NP (NN score) (NN coefficient)) (PP (IN of) (NP (QP (CD 0.912) (SYM +) (HYPH /) (SYM -) (CD 0.018)))))) (-RRB- -RRB-)))) (. .))
(S (NP (NNP Iliopsoas) (NN muscle) (NNS volumes)) (VP (VBD were) (ADVP (RB successfully)) (VP (VBN measured) (PP (IN in) (NP (DT all) (CD 5,000) (NNS participants))))) (. .))
(S (NP (NNP Iliopsoas) (NN volume)) (VP (VBD was) (ADJP (ADJP (JJR greater)) (PP (IN in) (ADJP (JJ male)))) (PP (VBN compared) (PP (IN with) (NP (JJ female) (NNS subjects))))) (. .))
(S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (ADJP (JJ small) (CC but) (JJ significant)) (NN asymmetry)) (PP (IN between) (NP (NP (ADJP (JJ left) (CC and) (JJ right)) (NNS iliopsoas)) (NP (NN muscle) (NNS volumes)))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD found) (SBAR (SBAR (IN that) (S (NP (NN iliopsoas) (NN volume)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN related) (PP (IN to) (NP (NN height) (, ,) (NN BMI) (CC and) (NN age))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT an) (NN acceleration)) (PP (IN in) (NP (NP (NN muscle) (NN volume) (NN decrease)) (PP (IN in) (NP (NP (NNS men)) (PP (IN with) (NP (NN age))))))))))))) (. .))
(S (NP (PRP$ Our) (NN method)) (VP (VBZ provides) (NP (DT a) (JJ robust) (NN technique)) (PP (IN for) (S (VP (VBG measuring) (NP (NP (NNS iliopsoas) (NML (NN muscle) (NN volume))) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN applied) (PP (IN to) (NP (JJ large) (NNS cohorts))))))))))))) (. .))
